Aim: To assess if six months of treatment with CPAP associated with conventional drug therapy, contribute to improved glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome SAHS)
Main objective: To assess the effect of 6 months of CPAP treatment associated with conventional drug therapy on glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome (SAHS)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
61
Treatment with titred CPAP nasal during the nighttime
Hospital Universitario La Paz- IdiPaz
Madrid, Madrid, Spain
Glycemic control
To assess the effect of 6 months of CPAP therapy and conventional treatment on glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome (SAHS)
Time frame: Six months
To determine additional effects of CPAP on insulin resistance in patients with type 2 diabetes and SAHS.
. Determine the medium term additional effect of CPAP on insulin resistance in patients with type 2 diabetes and SAHS.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.